Genotyping the Future: Scientists’ Expectations about Race/ Ethnicity after BiDil
Version of Record online: 22 AUG 2008
© 2008 American Society of Law, Medicine & Ethics, Inc.
The Journal of Law, Medicine & Ethics
Volume 36, Issue 3, pages 464–470, September 2008
How to Cite
Tutton, R., Smart, A., Martin, P. A., Ashcroft, R. and Ellison, G. T. H. (2008), Genotyping the Future: Scientists’ Expectations about Race/ Ethnicity after BiDil. The Journal of Law, Medicine & Ethics, 36: 464–470. doi: 10.1111/j.1748-720X.2008.292.x
- Issue online: 22 AUG 2008
- Version of Record online: 22 AUG 2008
The ongoing debate about the FDA approval of BiDil in 2005 demonstrates how the first racially/ethnically licensed drug is entangled in both Utopian and dystopian future visions about the continued saliency of race/ethnicity in science and medicine. Drawing on the sociology of expectations, this paper analyzes how scientists in the field of pharmacogenetics are constructing certain visions of the future with respect to the use of social categories of race/ethnicity and the impact of high-throughput genotyping technologies that promise to transform scientific practices.